This study is undertaken to evaluate the effectiveness of currently licensed varicella vaccines under conditions of routine use in a setting where varicella vaccine is included in the childhood immunization calendar.
Observational, multicenter, population-based, matched case-control study conducted in selected pediatric practices in the Munich area.
Study Type
OBSERVATIONAL
Enrollment
1,012
Occurrence of PCR-confirmed varicella cases in children administered one dose of Varilrix™ (≥ 28 days after receipt of vaccine) or in unvaccinated children.
Occurrence of PCR-confirmed varicella cases in children administered one dose of commercially-available varicella vaccine (≥ 28 days after receipt of vaccine) or in unvaccinated children
Occurrence of PCR-confirmed severe varicella cases in children administered one dose of Varilrix™ (≥ 28 days after receipt of vaccine) or in unvaccinated children
Occurrence of PCR-confirmed severe varicella cases in children administered one dose of commercially-available varicella vaccine (≥ 28 days after receipt of vaccine) or in unvaccinated children
Occurrence of clinical varicella cases in children administered one dose of commercially-available varicella vaccine (≥ 28 days after receipt of vaccine) or in unvaccinated children
Occurrence of clinical varicella cases in children administered two doses of commercially-available varicella vaccine (≥ 28 days after receipt of the second dose of vaccine) or in unvaccinated children
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
GSK Investigational Site
Baldham, Bavaria, Germany
GSK Investigational Site
Deisenhofen, Bavaria, Germany
GSK Investigational Site
Freising, Bavaria, Germany
GSK Investigational Site
Fürstenfeldbruck, Bavaria, Germany
GSK Investigational Site
Gilching, Bavaria, Germany
GSK Investigational Site
Grafing, Bavaria, Germany
GSK Investigational Site
Grafrath, Bavaria, Germany
GSK Investigational Site
Kirchheim, Bavaria, Germany
GSK Investigational Site
Munich, Bavaria, Germany
GSK Investigational Site
Munich, Bavaria, Germany
...and 23 more locations